Victrex plc (LON:VCT - Get Free Report) hit a new 52-week low on Tuesday . The company traded as low as GBX 667.62 ($9.01) and last traded at GBX 719 ($9.70), with a volume of 2403428 shares traded. The stock had previously closed at GBX 786 ($10.60).
Analyst Ratings Changes
A number of research firms have commented on VCT. Deutsche Bank Aktiengesellschaft lowered Victrex to a "hold" rating and lowered their price objective for the stock from GBX 990 ($13.35) to GBX 850 ($11.47) in a research note on Tuesday. JPMorgan Chase & Co. cut their target price on Victrex from GBX 940 ($12.68) to GBX 818 ($11.03) and set a "neutral" rating for the company in a research note on Wednesday.
Read Our Latest Report on Victrex
Victrex Stock Down 0.5%
The firm has a market capitalization of £631.91 million, a price-to-earnings ratio of 20.58, a P/E/G ratio of 1.92 and a beta of 0.69. The stock has a fifty day moving average of GBX 793.01 and a two-hundred day moving average of GBX 888.34. The company has a debt-to-equity ratio of 10.93, a current ratio of 4.39 and a quick ratio of 1.99.
Victrex (LON:VCT - Get Free Report) last issued its quarterly earnings results on Monday, May 12th. The company reported GBX 22.60 ($0.30) EPS for the quarter. Victrex had a net margin of 10.81% and a return on equity of 6.67%. Sell-side analysts anticipate that Victrex plc will post 73.1078905 earnings per share for the current year.
Insider Activity
In other news, insider David Thomas bought 1,158 shares of Victrex stock in a transaction dated Tuesday, May 13th. The stock was bought at an average cost of GBX 846 ($11.41) per share, for a total transaction of £9,796.68 ($13,215.54). Also, insider Dame Vivienne Cox bought 2,747 shares of Victrex stock in a transaction dated Tuesday, July 8th. The stock was purchased at an average price of GBX 721 ($9.73) per share, with a total value of £19,805.87 ($26,717.75). Company insiders own 1.64% of the company's stock.
About Victrex
(
Get Free Report)
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
Further Reading
Before you consider Victrex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Victrex wasn't on the list.
While Victrex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
